1st Manufacturer of generic syrups in France H3pharma Group Products Services Contacts FOR MORE INFO ON THE H3PHARMA GROUP VISIT Our Corporate Site www.H3pharma.fr Powered by Signenoir H2PHARMA WHO ARE WE? For 15 years, H2 Pharma (formerly Aerocid) has specialized in the manufacture of "non-sterile liquids" (syrups, drinkable solutions, mouthwashes) and demonstrates its know-how by developing, under the control of H3 Santé , almost all of the generics in vials (non-sterile) released in recent years. The Cachan site was not suitable for accommodating the large volumes of generics under development, the decision to build a brand new production unit was taken in October 2006 and the realization of the Bois d'Arcy site quickly took shape. (PC January 2007). The specifications for the development of the construction of this 9,000 m2 factory were complex but were based on 4 fundamental principles: Simplicity of incoming and outgoing flows Maximum separation between technical and pharmaceutical Ultra automation and dedicated lines Scalable use of the site The complete construction (from the earthworks to the wiring of the machines) only lasted 15 months from July 2007 to October 2008. The blanks and qualifications lasted until March 2009 and production started on April 2, 2009. The site de Cachan produced 15 million bottles in 2008. The Bois d'Arcy site produced 15 million bottles over the 9 months of 2009. This figure is expected to be 25 million for 2010 and 35 million for 2011. H2 pharma settles in Bois-d'Arcy Implementation The company H2 Pharma , French first generic producer of syrups, has launched a production unit in Bois-d'Arcy (Yvelines). The latter replaces the old factory of the company H2Pharma , located in Cachan (Hauts-de-Seine) and which produced 15 million units per year. Its completion for 15 million euros strengthens the industrial tool of the H2 Pharma group . 50 million bottles and solutions will come out of the highly automated lines of Bois-d'Arcy with the possibility of extension bringing production to 70 million units. Built in the middle of the Bois-d'Arcy forest, the H2 Pharma factoryrespects strict environmental standards with, in particular, a wooden facade. H2 Pharma, already number 1 in France for the manufacture of generic syrups, the company aims to become a leader in this market segment in Europe according to its president Henry Hassid. For this, the H2Pharma group , which achieved 17 million turnover in 2008, H2 Pharma is not content to be a simple subcontractor of generic laboratories, but conducts its own research policy and develops research files. '' Marketing Authorization (AMM). H2Pharma France was present at CPHI / BIO PH From 05/10/2010 to 07/10/2010 Paris North Villepinte